Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1999
08/03/1999US5932552 Keratin-based hydrogel for biomedical applications and method of production
08/03/1999US5932551 Inhibitors of matrix metalloendoproteinase-mediated diseases
08/03/1999US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease
08/03/1999US5932548 Lysine containing peptides for treatment of heart disease
08/03/1999US5932547 Non-aqueous polar aprotic peptide formulations
08/03/1999US5932546 Peptides and compounds that bind to the thrombopoietin receptor
08/03/1999US5932545 Antiangiogenic drug to treat cancer, arthritis and retinopathy
08/03/1999US5932543 Cyclic peptide antifungal agents and process for preparation thereof
08/03/1999US5932542 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
08/03/1999US5932541 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-l-histidyl-l-prolinam ide or a pharmaceutically acceptable salt thereof
08/03/1999US5932540 Vascular endothelial growth factor 2
08/03/1999US5932538 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/03/1999US5932537 Contacting a mammalian cell that is responsive to interleukin-1 with an intracellular interleukin-1 receptor antagonist (?icil-1ra?) not normally found in said cell.
08/03/1999US5932536 Compositions for neutralization of lipopolysaccharides
08/03/1999US5932483 Synthetic peptide and its uses
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932475 Human nucleolin-like protein
08/03/1999US5932471 DNA encoding chimeric toxin
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932469 Antimicrobial polypeptide, nucleic acid, and methods of use
08/03/1999US5932465 Phosphodiesterase 8A
08/03/1999US5932461 Seryl tRNA synthetase from Staphylococcus aureus
08/03/1999US5932459 Artificial tissues, methods for the production and the use thereof
08/03/1999US5932448 Bispecific antibody heterodimers
08/03/1999US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present
08/03/1999US5932446 Hmvab41
08/03/1999US5932445 Signal peptide-containing proteins
08/03/1999US5932444 Vacuolar atpase subunit AC45
08/03/1999US5932443 Human antigens
08/03/1999US5932442 Human regulatory molecules
08/03/1999US5932433 Biotinylation of proteins
08/03/1999US5932427 In vitro assay system for identifying compositions useful for stimulating B cells
08/03/1999US5932425 Compositions and methods for modulating cellular NF-κB activation
08/03/1999US5932424 Screening compounds for binding sensitivity to peptide transport proteins in culture
08/03/1999US5932423 Cyclic nucleotide phosphodiesterases
08/03/1999US5932422 Determining whether transformed mammalian cell will respond to drug by measuring level of enzyme and comparing to level in normal cell, increased level of enzyme indicates resistance; diagnosing resistant tumor cells
08/03/1999US5932420 Amplification by polymerase chain reaction
08/03/1999US5932417 Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells
08/03/1999US5932410 Assay for the detection of proteases
08/03/1999US5932259 Basic peptide fraction is obtained by hydrolyzing the basic protein fraction with a protease. useful for treating or preventing bone diseases such as osteoporosis.
08/03/1999US5932245 Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds
08/03/1999US5932244 Liposomal human calcitonin gene-related peptide composition and preparation of the same
08/03/1999US5932241 Cationic lipid DNA complexes for gene targeting
08/03/1999US5932236 Pharmaceutical composition and methods for using it
08/03/1999US5932222 Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use
08/03/1999US5932218 Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1
08/03/1999US5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells
08/03/1999US5932216 Antibodies to bone morphogenetic protein-10 (BMP-10)
08/03/1999US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema
08/03/1999US5932214 Treatment for inflammatory bowel disease with VLA-4 blockers
08/03/1999US5932213 Modified plasmin precursors with resistance to inhibitors of plasmin
08/03/1999US5932212 Crosslinked protein crystal formulations and their use as catalysts in organic solvents
08/03/1999US5932211 Glycosylation variants of iduronate 2-sulfatase
08/03/1999US5932210 Partial or total deletion of the adenoviral protein ix dna and having a gene encoding a foreign protein or a functional fragment or mutant thereof.
08/03/1999US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine
08/03/1999US5932189 Radiotherapy, radiodiagnosis peptides
08/03/1999CA2261086A1 Inhibition of mmp-2 activity by oral bacteria and siderophores
08/03/1999CA2017039C Gel filtration of heat treated factor viii
08/03/1999CA2002924C Anti-thrombins
08/03/1999CA1340692C Method of potentiating an immune response and compositions therefor
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999038011A1 Circulating insulin-like growth factor-i and prostate cancer risk
07/29/1999WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor
07/29/1999WO1999037803A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
07/29/1999WO1999037800A1 Antimicrobial compounds
07/29/1999WO1999037791A1 Multipurpose antibody derivatives
07/29/1999WO1999037790A1 Human calcineurin b-like protein
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications
07/29/1999WO1999037779A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same
07/29/1999WO1999037778A2 Compositions and methods for detecting and treating prostate cancer
07/29/1999WO1999037777A2 Differentiation-associated sequences and methods of use therefor
07/29/1999WO1999037776A1 Methods for modulating angiogenesis
07/29/1999WO1999037775A2 Compositions and methods for detecting and treating breast cancer
07/29/1999WO1999037774A2 Differentiation-associated sequences and methods of use therefor
07/29/1999WO1999037773A1 Acpl dna and polypeptides
07/29/1999WO1999037772A1 Il-18 receptors
07/29/1999WO1999037771A1 A new human tumor-associated gene
07/29/1999WO1999037769A1 Orphan receptors
07/29/1999WO1999037766A2 A purified polynucleotide sequence containing a region encoding a mutated zap-70 protein or a fragment thereof
07/29/1999WO1999037762A1 Trek-1 like two pore potassium channel
07/29/1999WO1999037760A1 Inhibition of cytokine production
07/29/1999WO1999037757A1 Cubilin protein, dna sequences encoding cubilin and uses thereof
07/29/1999WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN
07/29/1999WO1999037679A1 Ligand receptors and uses therefor
07/29/1999WO1999037678A2 Antimicrobial peptides
07/29/1999WO1999037676A1 Recombinant human mannan-binding proteins and process for producing the same
07/29/1999WO1999037675A1 Nucleic acid sequences encoding capsaicin receptors
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037671A1 Vegf related gene and protein
07/29/1999WO1999037669A1 PEPTIDES WITH β1 INTEGRIN SUBUNIT DEPENDENT CELL ADHESION MODULATING ACTIVITY
07/29/1999WO1999037668A1 Thrombin inhibitors
07/29/1999WO1999037667A1 Efflux pump inhibitors
07/29/1999WO1999037666A1 α-KETOAMIDE INHIBITORS OF 20S PROTEASOME
07/29/1999WO1999037665A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
07/29/1999WO1999037664A1 Novel peptides having biological activity
07/29/1999WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides
07/29/1999WO1999037611A1 Heterocyclic amidines as callicrein protease inhibitors
07/29/1999WO1999037337A2 Prostheses with associated growth factors
1 ... 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 ... 3163